Have compensatory mutations facilitated the current epidemic of multidrug-resistant tuberculosis?-Reference-Cited by-同舟云学术

Have compensatory mutations facilitated the current epidemic of multidrug-resistant tuberculosis?

Published:2018-06-06 Issue:1 Volume:7 Page:1-8
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Liu Qingyun¹²,Zuo Tianyu¹,Xu Peng³,Jiang Qi¹²^ORCID,Wu Jie⁴,Gan Mingyu¹²,Yang Chongguang⁵,Prakash Ravi¹,Zhu Guofeng⁴,Takiff Howard E.⁶,Gao Qian¹²

Affiliation:

1. Key Laboratory of Medical Molecular Virology at the School of Basic Medical Sciences, Shanghai Medical College, Shanghai Public Health Clinical CenterFudan University Shanghai China

2. Shenzhen Center for Chronic Disease Control Shenzhen China

3. Key Laboratory of Characteristic Infectious Disease & Bio-safety Development of Guizhou Province Education DepartmentZunyi Medical University Zunyi Guizhou China

4. Shanghai Municipal Center for Disease Control and Prevention Shanghai China

5. Department of Epidemiology of Microbial Diseases, School of Public HealthYale University New Haven CT USA

6. Unité de Génétique Mycobacterienne, Institut Pasteur Paris France

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/s41426-018-0101-6.pdf

Reference34 articles.

1. The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis

2. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis